Following a recent opinion written from the Department of Justice claiming that federal law permits mandating an emergency use vaccine, non-profit Informed Consent Action Network’s attorneys issued a response disputing the conclusion in this opinion.

On July 26, 2021, at the request of the White House, the DOJ’s Acting Assistant AG released an opinion claiming the Food, Drug and Cosmetic Act, Section 564 permits mandating an emergency use vaccine. Section 564 states that for all emergency use products, i.e. unlicensed medical products, individuals must be informed of “the option to accept or refuse administration of the product.” 

ICAN counsel’s response explains why the DOJ’s conclusion that an unlicensed medical product can be mandated runs contrary to the text of Section 564, its statutory framework, the history surrounding its passage, and its consistent interpretation by the FDA, CDC, DCO, and other federal agencies. 

It is also illogical for Congress to provide in Section 564 that individuals must be informed of “the option to accept or refuse administration of the product” but permit expelling an individual from school, employment, or the military if they refuse.

“The Department of Justice is supposed to blindly enforce the law, without political persuasion.  This DOJ opinion written for the White House falls far short of this fundamental responsibility to the American people,” says Del Bigtree, founder of ICAN, Emmy Award winner and host of the online weekly investigative news program “The HighWire With Del Bigtree.”

“The long-standing principal that no individual should be coerced or unduly influenced to accept an unlicensed medical product should not be abandoned based on the political needs of the day,” Bigtree says. “Whatever short term gain the President and the DOJ believe will be achieved by casting aside this fundamental protection pales in comparison to the harm likely to result in the future, if not from this product, but from others, by permitting mandating people to receive unlicensed medical products.”

ICAN’s response requests that the DOJ officials that drafted the opinion reconsider their interpretation and guidance regarding Section 564 and revise it, and that the DOJ fulfill its duty by enforcing this provision which prohibits mandates of an EUA product, rather than casting this important right aside.

“We live in an unprecedented time, making it all the more important to hold tight to the principles that we have learned from history,” Bigtree says.

READ THE PRESS RELEASE HERE:
https://www.einpresswire.com/article/548512480/informed-consent-action-network-s-attorneys-challenge-doj-mandatory-vaccine-opinion?r=pabnzgloZIZNKZYRuw

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy